Mitchel L. Zoler, PhD
![1]()
News
Clinicians, CMS confer over heart failure–readmission penalty
April 10, 2019
Evidence showed the CMS hospital penalty for excess heart failure readmissions has had unintended adverse consequences and needs fixing.
![1]()
News
Occurrence of pulmonary embolisms in hospitalized patients nearly doubled during 2004-2015
March 24, 2019
NEW ORLEANS – National Inpatient Sample data showed that during 2004-2015 hospitalized U.S. patients with a PE diagnosis jumped by 80%.
![1]()
News
Higher blood pressure after thrombectomy links with bad stroke outcomes
March 12, 2019
HONOLULU – Observational data showed that ischemic stroke patients with systolic blood pressure above 158 mm Hg after thrombectomy had worse outcomes.
![1]()
News
Noncardiac surgery has 7% covert stroke rate in elderly
February 19, 2019
HONOLULU – Covert strokes were linked with a doubled rate of cognitive decline in older patients after noncardiac surgery.
![1]()
News
Intensive insulin added no benefit for hyperglycemia after ischemic stroke
February 7, 2019
Results from a large RCT showed intensive and standard insulin regimens produced similar clinical outcomes after an acute ischemic stroke.
![1]()
News
Revised U.S. A fib guidelines revamp anticoagulation
January 29, 2019
The first revision of U.S. guidelines for managing atrial fibrillation since 2014 favor DOACs over warfarin.
![1]()
News
RE-SPECT ESUS: Dabigatran matched aspirin for second stroke prevention
January 9, 2019
MONTREAL – In an international trial with 5,390 patients, dabigatran proved no better than aspirin for second stroke prevention following ESUS.
![1]()
News
New diabetes drugs solidify their cardiovascular and renal benefits
January 7, 2019
CHICAGO – Empagliflozin’s heart failure and renal benefits surprised when reported in 2015. The evidence has grown stronger and broader since.
![1]()
News
Acute stroke thrombolysis worked safely despite GI bleed or malignancy
December 7, 2018
CHICAGO – Current guidelines contraindicate acute stroke thrombolysis in patients with GI bleed or malignancy, but a new analysis suggests it’s safe.
![1]()
Video
ARISTOPHANES: Apixaban edges other DOACS for octogenarians
December 2, 2018
CHICAGO – Insurance claims data from more than 50,000 U.S. octogenarians on a DOAC showed apixaban worked best and caused the fewest major bleeds.
